Embedded Files
VERIFY Trial
VERIFY Trial
VERIFY will validate biomarkers (MRI, TMS) of upper extremity (UE) motor outcome in the acute ischemic stroke window.
TELEREHAB-2 Trial
TELEREHAB-2 Trial
The TR-2 trial is a controlled, assessor-blind, randomized, phase III superiority trial that to improve patient outcomes after stroke by vastly increasing therapy doses and access.
Report abuse